BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 17, 2020
View Archived Issues
Stromal cell subtypes identified in TNBC
Read More
From variants to treatments in neurology
Read More
New selective NKCC1 inhibitor for neurological conditions with impaired chloride ion homeostasis
Read More
LION/repRNA-CoV2S vaccine candidate shows efficacy in vivo
Read More
Phase III data presented for incobotulinumtoxin A in post-stroke upper-limb spasticity
Read More
Beijing Scitech-Mq Pharmaceuticals patents multitarget inhibitors
Read More
New phosphodiesterase PDE3A and PDE3B inhibitors disclosed by Bayer, The Broad Institute
Read More
Medshine Discovery discovers PD-L1 expression inhibitors
Read More
Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical identify agents targeting 5-HT2A/DRD3
Read More
Aeovian Pharmaceuticals identifies new mTORC1 inhibitors
Read More
Vivozon halts phase III study of opiranserin due to COVID-19 outbreak in the U.S.
Read More
Homozygous mutations in BTG4 are responsible for the phenotype of zygotic cleavage failure
Read More
FDA approves Enspryng for neuromyelitis optica spectrum disorder
Read More
Missense variants in the TRIP13 gene cause oocyte meiotic arrest resulting in female infertility
Read More
Discovery of autoantibody biomarkers for SLE diagnosis using a 2-phase proteome microarray strategy
Read More
Dosing initiates in phase IIa study of ASC-22 in patients with chronic hepatitis B
Read More
Starpharma and Chase Sun to develop novel DEP nanoparticle formulations
Read More
Specific miRNA-1 oxidation encodes cardiac hypertrophy
Read More
Kiadis announces K-NK-cell technology program for the development of COVID-19 therapy
Read More
Novavax initiates phase IIb efficacy trial of NVX-CoV2373 in South Africa
Read More
